US Patent Issued to Beam Therapeutics, UCL BUSINESS on April 7 for "Compositions and methods for treatment of liquid cancers" (British, American Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,301, issued on April 7, was assigned to Beam Therapeutics Inc. (Cambridge, Mass.) and UCL BUSINESS LTD. (London).

"Compositions and methods for treatment of liquid cancers" was invented by Jason Michael Gehrke (Cambridge, Mass.), Aaron D. Edwards (Cambridge, Mass.), Ryan Murray (Cambridge, Mass.) and Waseem Qasim (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "As described below, the present invention features genetically modified immune cells having enhanced anti-neoplasia activity, resistance to immune suppression, and decreased risk of eliciting a graft versus host reaction, or a combination thereof. The present invention also features met...